HUP1900193A1 - Szelektív hisztamin H3 receptor antagonista savaddíciós sók és eljárás elõállításukra - Google Patents
Szelektív hisztamin H3 receptor antagonista savaddíciós sók és eljárás elõállításukraInfo
- Publication number
- HUP1900193A1 HUP1900193A1 HU1900193A HUP1900193A HUP1900193A1 HU P1900193 A1 HUP1900193 A1 HU P1900193A1 HU 1900193 A HU1900193 A HU 1900193A HU P1900193 A HUP1900193 A HU P1900193A HU P1900193 A1 HUP1900193 A1 HU P1900193A1
- Authority
- HU
- Hungary
- Prior art keywords
- histamin
- selective
- preparation
- acid
- addition salts
- Prior art date
Links
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 title 1
- 239000003382 histamine H3 receptor agonist Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1900193A HU231335B1 (hu) | 2019-05-31 | 2019-05-31 | Szelektív hisztamin H3 receptor antagonista savaddíciós sók és eljárás előállításukra |
PCT/IB2020/055105 WO2020240490A1 (en) | 2019-05-31 | 2020-05-29 | Selective histamine h3 antagonist acid addition salts and process for the preparation thereof |
JP2021570822A JP2022534974A (ja) | 2019-05-31 | 2020-05-29 | 選択的ヒスタミンh3アンタゴニスト酸付加塩およびその調製方法 |
CN202080040296.3A CN113906016A (zh) | 2019-05-31 | 2020-05-29 | 选择性组胺h3拮抗剂酸加成盐及其制备方法 |
CA3141698A CA3141698A1 (en) | 2019-05-31 | 2020-05-29 | Selective histamine h3 antagonist acid addition salts and process for the preparation thereof |
US17/615,176 US20220235030A1 (en) | 2019-05-31 | 2020-05-29 | Selective histamine h3 antagonist acid addition salts and process for the preparation thereof |
EP20730747.1A EP3976598B1 (en) | 2019-05-31 | 2020-05-29 | Selective histamine h3 antagonist acid addition salts and process for the preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1900193A HU231335B1 (hu) | 2019-05-31 | 2019-05-31 | Szelektív hisztamin H3 receptor antagonista savaddíciós sók és eljárás előállításukra |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP1900193A1 true HUP1900193A1 (hu) | 2020-12-28 |
HU231335B1 HU231335B1 (hu) | 2023-01-28 |
Family
ID=89992918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUP1900193A HU231335B1 (hu) | 2019-05-31 | 2019-05-31 | Szelektív hisztamin H3 receptor antagonista savaddíciós sók és eljárás előállításukra |
Country Status (7)
Country | Link |
---|---|
US (1) | US20220235030A1 (hu) |
EP (1) | EP3976598B1 (hu) |
JP (1) | JP2022534974A (hu) |
CN (1) | CN113906016A (hu) |
CA (1) | CA3141698A1 (hu) |
HU (1) | HU231335B1 (hu) |
WO (1) | WO2020240490A1 (hu) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP1300139A2 (en) * | 2013-03-06 | 2014-09-29 | Richter Gedeon Nyrt | Phenoxypiperidine h3 antagonists |
-
2019
- 2019-05-31 HU HUP1900193A patent/HU231335B1/hu unknown
-
2020
- 2020-05-29 CN CN202080040296.3A patent/CN113906016A/zh active Pending
- 2020-05-29 US US17/615,176 patent/US20220235030A1/en active Pending
- 2020-05-29 EP EP20730747.1A patent/EP3976598B1/en active Active
- 2020-05-29 WO PCT/IB2020/055105 patent/WO2020240490A1/en unknown
- 2020-05-29 CA CA3141698A patent/CA3141698A1/en active Pending
- 2020-05-29 JP JP2021570822A patent/JP2022534974A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3976598C0 (en) | 2024-03-27 |
HU231335B1 (hu) | 2023-01-28 |
US20220235030A1 (en) | 2022-07-28 |
CN113906016A (zh) | 2022-01-07 |
EP3976598B1 (en) | 2024-03-27 |
EP3976598A1 (en) | 2022-04-06 |
WO2020240490A1 (en) | 2020-12-03 |
CA3141698A1 (en) | 2020-12-03 |
JP2022534974A (ja) | 2022-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL283362A (en) | A thrbeta receptor agonist compound and a method for its preparation and use | |
IL284446A (en) | A method for preparing a dual gip/glp1 agonist | |
LT3610875T (lt) | Opioido (mor) agonisto druska, jo fumarato druskos i kristalinė forma ir jos gavimo būdas | |
IL281464A (en) | Crystal forms of a paranoid X receptor agonist | |
EP3965765A4 (en) | OPIOID RECEPTOR ANTAGONIST PRODRUGS | |
IL292639A (en) | Heterocyclic nmda antagonist | |
GB2603330B (en) | Heterocyclic THR-B receptor agonist compound and preparation method and use therefor | |
EP3638282A4 (en) | HYDROCHLORIDE SALTS OF C5A RECEPTORAGONIST PEPTIDES | |
SG11202007896YA (en) | Compounds having s1p5 receptor agonistic activity | |
HUP1900193A1 (hu) | Szelektív hisztamin H3 receptor antagonista savaddíciós sók és eljárás elõállításukra | |
IL289066A (en) | Preparations and methods for treating acute cannabinoid overdose using a cannabinoid receptor antagonist | |
IL286054A (en) | A process for the preparation of a modified imidazoquinoline | |
IL264708B (en) | History of n-[2-(4-phenoxypiperidin-1-yl)-2-(3,1-thiazol-5-yl)ethyl]benzamide and n-[2-(4-benzyloxypiperidin-1-yl)-2- (3,1-thiazol-5-yl)ethyl]benzamide-modified p2x7 receptor antagonists | |
ZA202101279B (en) | A process for the preparation of a modified release multiple unit oral dosage form of doxylamine succinate and pyridoxine hydrochloride | |
EP3803035C0 (en) | MODULAR HEAD FOR WELL TUBES | |
PT3643704T (pt) | Novos intermediários para a preparação de hidrocloreto de remifentanil | |
PL3720841T3 (pl) | Sposób otrzymywania kryształów hydratu chlorowodorku l-cysteiny naturalnej za pomocą chromatografii ciągłej | |
EP3681880A4 (en) | PROCESS FOR THE PREPARATION OF CRYSTALLINE TIPIRACIL HYDROCHLORIDE | |
PT3819293T (pt) | Antagonista do receptor 2 da angiotensina na forma de sal e forma cristalina e método de preparação do mesmo | |
EP4324827A4 (en) | PHARMACEUTICALLY ACCEPTABLE SALT OF A SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST AND CRYSTALLINE FORM THEREOF | |
GB201910515D0 (en) | GLP-1 Receptor antagonists | |
HUP1800089A2 (en) | Process for the preparation of the b polymorph form of treprostinil-diethanol-amine salt |